<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>AIMS: We aimed to evaluate the association between <z:e sem="disease" ids="C0025945" disease_type="Disease or Syndrome" abbrv="">diabetic microangiopathy</z:e> and subclinical <z:hpo ids='HP_0002621'>atherosclerosis</z:hpo> as a marker of <z:e sem="disease" ids="C0007222" disease_type="Disease or Syndrome" abbrv="CVD">cardiovascular disease</z:e> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CVD</z:e>) risk in patients with newly diagnosed type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> </plain></SENT>
<SENT sid="1" pm="."><plain>METHODS: A total of 142 newly diagnosed type 2 diabetics who were free from <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CVD</z:e> underwent evaluation of <z:e sem="disease" ids="C0025945" disease_type="Disease or Syndrome" abbrv="">diabetic microangiopathy</z:e> </plain></SENT>
<SENT sid="2" pm="."><plain>Subclinical <z:hpo ids='HP_0002621'>atherosclerosis</z:hpo> was assessed by measuring carotid intima-media thickness (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">IMT</z:e>), and the 10-year absolute risk of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CVD</z:e> was estimated using the UK Prospective <z:mp ids='MP_0002055'>Diabetes</z:mp> Study (UKPDS) Risk Engine </plain></SENT>
<SENT sid="3" pm="."><plain>RESULTS: Subclinical <z:hpo ids='HP_0002621'>atherosclerosis</z:hpo> was found in 27 subjects (19.0%) </plain></SENT>
<SENT sid="4" pm="."><plain>The rates of <z:hpo ids='HP_0000822'>hypertension</z:hpo> and diabetic <z:hpo ids='HP_0000488'>retinopathy</z:hpo> were significantly higher among patients with subclinical <z:hpo ids='HP_0002621'>atherosclerosis</z:hpo> </plain></SENT>
<SENT sid="5" pm="."><plain>The UKPDS 10-year risk for <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CVD</z:e> was significantly increased in subjects with subclinical <z:hpo ids='HP_0002621'>atherosclerosis</z:hpo> </plain></SENT>
<SENT sid="6" pm="."><plain>Old age, <z:hpo ids='HP_0000822'>hypertension</z:hpo> and the presence of diabetic <z:hpo ids='HP_0000488'>retinopathy</z:hpo> showed a significant association to subclinical <z:hpo ids='HP_0002621'>atherosclerosis</z:hpo> after further adjustments for gender, body mass index, smoking status, HbA1c, <z:chebi fb="4" ids="47775">HDL cholesterol</z:chebi>, <z:chebi fb="1" ids="47774">LDL cholesterol</z:chebi> and the presence of diabetic <z:hpo ids='HP_0000112'>nephropathy</z:hpo> </plain></SENT>
<SENT sid="7" pm="."><plain>CONCLUSIONS: This study shows that diabetic <z:hpo ids='HP_0000488'>retinopathy</z:hpo> is an independent risk marker for subclinical <z:hpo ids='HP_0002621'>atherosclerosis</z:hpo> in patients with newly diagnosed type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> </plain></SENT>
<SENT sid="8" pm="."><plain>We suggest that a diagnosis of diabetic <z:hpo ids='HP_0000488'>retinopathy</z:hpo> may warrant a more careful cardiovascular assessment even in the early stages of <z:mp ids='MP_0002055'>diabetes</z:mp> </plain></SENT>
</text></document>